American Century Companies’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,149
Closed -$266K 2945
2026
Q1
$266K Sell
12,149
-85,987
-88% -$1.91M ﹤0.01% 2659
2025
Q4
$2.11M Buy
98,136
+34,830
+55% +$611K ﹤0.01% 2070
2025
Q3
$741K Buy
+63,306
New +$630K ﹤0.01% 2397

Other funds holding IMNM

American Century Companies's IMNM Position: Q2 2026 in Review

American Century Companies sold out of Immunome (IMNM) in Q2 2026, closing a stake of 12,149 shares — an estimated $266K sold.

American Century Companies first reported a position in IMNM in Q3 2025 and held it in 3 quarters. The position peaked at $2.11M in Q4 2025. 188 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • American Century Companies reported no remaining Immunome position as of Q2 2026 after selling out during the quarter.
  • American Century Companies sold 12,149 Immunome shares in Q2 2026, an estimated $266K.
  • American Century Companies first reported a position in Immunome in Q3 2025 and held it in 3 quarters.
  • American Century Companies's Immunome position peaked at $2.11M in Q4 2025.
  • 188 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.